Abstract
Current indications for breast cancer screening in the male population are lacking, although family history of breast cancer may be such an indication. The authors describe a man with a history of clinically diagnosed right breast cancer who subsequently tested positive for the breast cancer susceptibility gene BRCA2 and received a diagnosis of mammographically detected left breast cancer at screening. The authors discuss the clinical implications of this approach to detecting male breast cancer.
Copyright RSNA, 2004
MeSH terms
-
Aged
-
BRCA2 Protein / genetics*
-
Biopsy, Needle
-
Breast / pathology
-
Breast Neoplasms, Male / diagnostic imaging
-
Breast Neoplasms, Male / genetics*
-
Breast Neoplasms, Male / pathology
-
Breast Neoplasms, Male / therapy
-
Carcinoma, Ductal, Breast / diagnostic imaging
-
Carcinoma, Ductal, Breast / genetics*
-
Carcinoma, Ductal, Breast / pathology
-
Carcinoma, Ductal, Breast / therapy
-
Carcinoma, Lobular / diagnostic imaging
-
Carcinoma, Lobular / genetics*
-
Carcinoma, Lobular / pathology
-
Carcinoma, Lobular / therapy
-
Follow-Up Studies
-
Germ-Line Mutation*
-
Humans
-
Male
-
Mass Screening*
-
Mastectomy
-
Neoplasm Staging
-
Neoplasms, Hormone-Dependent / diagnostic imaging
-
Neoplasms, Hormone-Dependent / genetics
-
Neoplasms, Hormone-Dependent / pathology
-
Neoplasms, Hormone-Dependent / therapy
-
Neoplasms, Multiple Primary / diagnostic imaging
-
Neoplasms, Multiple Primary / genetics*
-
Neoplasms, Multiple Primary / pathology
-
Neoplasms, Multiple Primary / therapy
-
Radiography
-
Receptors, Estrogen / analysis
-
Receptors, Progesterone / analysis
-
Reoperation
-
Sentinel Lymph Node Biopsy
Substances
-
BRCA2 Protein
-
Receptors, Estrogen
-
Receptors, Progesterone